Results 171 to 180 of about 5,643 (237)
CSIG-28. ATRX LOSS LEADS TO H3K4ME3-DRIVEN EPIGENETIC DYSREGULATION OF OLIGODENDROCYTE DIFFERENTIATION AND CELL CYCLE CONTROL IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA (DMG) [PDF]
Dana Messinger, Jina Patel, Robert Doherty, Daniel de la Nava, Madison Clausen, Kallen Schwark, Aleksandra Stańczak, Fareen Momen, Kennedy Kuchinski, Leslie A. Parsels, Joshua D. Parsels, Sunjong Ji, Mateus Mota, Sriram Venneti, Qiang Zhang, Meredith A. Morgan, Tingting Qin, Viveka Nand Yadav, Carl Koschmann +18 moreopenalex +1 more sourceAdult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach. [PDF]
Brain SciÇelebi A, Yıldırım B, Yıldırım E, Işık S, Çoban E, Bıyıklı E, Köstek O, Bayoğlu İV, Sarı M. +8 moreeuropepmc +1 more sourceSenescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG
, 2020 Ilango Balakrishnan, Etienne Danis, Angela Pierce, Krishna Madhavan, Dong Wang, Nathan Dahl, Sanford Bridget, Diane K. Birks, Nate Davidson, Dennis S. Metselaar, Michaël H. Meel, Rakeb Lemma, Andrew M. Donson, Trinka Vijmasi, Hiroaki Katagi, Ismail Sola, Susan Fosmire, Irina Alimova, Jenna Steiner, Ahmed Gilani, Esther Hulleman, Natalie J. Serkova, Rintaro Hashizume, Cynthia Hawkins, Ángel M. Carcaboso, Nalin Gupta, Michelle Monje, Nada Jabado, Kenneth L. Jones, Nicholas K. Foreman, Adam Green, Rajeev Vibhakar, Sujatha Venkataraman +32 moreopenalex +1 more sourceThe Biological Behavior of High-Grade Glioma in H3K27M Mutant Circumscribed Midline Gliomas
, 2021 Hainan Li, Jieyun Tan, Mingyao Lai, Wendan Chen, Minting Liu, Zhaoming Zhou, Dabiao Deng, Baijie Cheng, Chongzuo Fan, Linbo Cai, Zhi Li +10 moreopenalex +1 more sourceAdaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation. [PDF]
J NeurooncolLiu J, Ha JH, Abikenari M, Sjoholm MA, Annagiri S, Ravi K, Bergsneider BH, Verma R, Theodros D, Medikonda R, Li G, Prolo LM, Monje M, Lim M. +13 moreeuropepmc +1 more sourceTable S13 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton S. Tarapore, Samuel Ramage, Andrew Chi, Patrick Y. Wen, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca A. Harrison, John de Groot, Minesh P. Mehta, Matthew D. Hall, Doured Daghistani, Timothy F. Cloughesy, Benjamin M. Ellingson, Kévin Beccaria, Pascale Varlet, Michelle M. Kim, Yoshie Umemura, Hugh Garton, Andrea Franson, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles Burant, Sophie L. Mottl, Rodrigo T. Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna Schwendeman, Debra Hawes, Fusheng Yang, Alexander R. Judkins, Daniel Wahl, Costas A. Lyssiotis, Daniel de la Nava, Marta M. Alonso, Augustine Eze, Jasper Spitzer, Susanne V. Schmidt, Ryan J. Duchatel, Matthew D. Dun, Jason E. Cain, Li Jiang, Sylwia A. Stopka, Gerard Baquer, Michael S. Regan, Mariella G. Filbin, Nathalie Y.R. Agar, Lili Zhao, Chandan Kumar‐Sinha, Rajen Mody, Arul M. Chinnaiyan, Ryo Kurokawa, Drew Pratt, Viveka Nand Yadav, Jacques Grill, Cassie Kline, Sabine Mueller, Adam Resnick, Javad Nazarian, Joshua E. Allen, Yazmín Odia, Sharon L. Gardner, Carl Koschmann +83 moreopenalex +1 more sourceEarly distant progression in adult Histone-3 K27-altered diffuse midline gliomas. [PDF]
J NeurooncolGrassl N, Suwala AK, Kessler T, Bunse L, Mildenberger I, Breckwoldt MO, Ratliff M, Brehmer S, Herold-Mende C, Etminan N, Wick W, Sahm F, Platten M, Sahm K. +13 moreeuropepmc +1 more source
